Dr. Konstantinos Leventakos
Dr. Konstantinos Leventakos is an innovative medical oncologist treating patients with all stages of lung cancer and malignant pleural mesothelioma at the Mayo Clinic in Rochester, Minnesota.
- Assistant Professor of Medicine and Oncology at Mayo Clinic Minnesota
- Pleural Specialist
- Expertise:
-
Immunotherapy
Clinical Trials
Chemotherapy - Speciality:
-
Oncology
- Gender:
-
Male
- Language:
-
English, Greek
Primary Location
- Other Doctors At This Location
-
Dr. Shanda H. BlackmonThoracic Surgeon and Medical Director of User Experience at Mayo Clinic Minnesota
Dr. Travis E. GrotzSurgical Oncologist at Mayo Clinic Minnesota
Dr. Anastasios DimouAssistant Professor in the Division of Medical Oncology at Mayo Clinic Minnesota
Dr. Anne-Marie G. SykesRadiation Oncologist at Mayo Clinic Minnesota
Dr. Arkadiusz Z. DudekMedical Oncologist
Dr. Aaron S. MansfieldMedical Oncologist
Free Mesothelioma Treatment Guide
- Expertise:
-
Immunotherapy
Clinical Trials
Chemotherapy - Speciality:
-
Oncology
- Gender:
-
Male
- Language:
-
English, Greek
Get to Know Dr. Konstantinos Leventakos
Medical oncologist Dr. Konstantinos Leventakos is a fourth-generation physician whose love of medicine and caring for patients at the Mayo Clinic is deeply rooted.
His clinical focus revolves around the multidisciplinary care of thoracic malignancies such as mesothelioma, particularly lung cancer, pleural mesothelioma and neuroendocrine tumors.
As an assistant professor at the Mayo Clinic College of Medicine and Science, Leventakos is dedicated to the personalization of treatment and improving the efficiency of clinical practice.
He believes strongly in clinical trial research, serving as principal investigator of four studies at the Mayo Clinic aimed at improving lung cancer treatment at various levels.
Leventakos has a special interest in the integration of artificial intelligence for clinical trial matching and the development of novel immunotherapy to combat cancer.
Specialties of Dr. Konstantinos Leventakos
- Pleural mesothelioma
- Thymic malignancies
- Small cell lung cancer
- Non-small cell lung cancer
- Neuroendocrine carcinoma
- Palliative care
- Artificial intelligence and clinical trial matching
Dr. Konstantinos Leventakos’ Experience and Medical Education
- Mayo Clinic Minnesota
- University of Athens Medical School (Ph.D.)
- Georgetown University Hospital and Washington Hospital Center (Residency)
- Attikon University Hospital, Athens (Residency)
- University of Texas MD Anderson Cancer Center (Fellowship)
- Medical School of University of Crete (M.D.)
Awards and Certifications
- Board certified in medical oncology, hematology and internal medicine
- Tow Shung Tan Humanism in Medicine Award
Publications of Dr. Konstantinos Leventakos
- Murphy, S.J. et al. (2019, September). Using Genomics to Differentiate Multiple Primaries From Metastatic Lung Cancer. Journal of Thoracic Oncology.
- Leventakos, K. et al. (2019, March 22). The Need to Prioritize and Re-prioritize Palliative Care Options: Smoking Cessation as a Case-in-Point. Current Treatment Options in Oncology.
- Harris, F.R. et al. (2019, February). Targeting HER2 in patient-derived xenograft ovarian cancer models sensitizes tumors to chemotherapy. Molecular Oncology.
- Leventakos, K. et al. (2017, September). Management of Multifocal Lung Cancer: Results of a Survey. Journal of Thoracic Oncology.
Watch Our Free Mesothelioma Webinars
Find Active Mesothelioma Clinical Trials
Mesothelioma Trust Funds
